Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in Q4 2023

European Healthtech startup funding raised during Q4 2023.

In Q4 2023, 120 European Healthtech companies closed 121 funding rounds and raised €771M in equity funding (excluding debt and grants), down 54.8% versus Q4 2022. Debt rounds added €66M. France led by capital raised, and Fongit Innovation Fund (FIF) was the most active investor. Data as of 20 Nov 2026.

Equity funding
€771M
-54.8% vs Q4 2022 · excl. debt & grants · +€66M debt
Funding rounds
121
-33.5% vs Q4 2022
Companies
120
Top country
France
Rank among sectors
#6
4.7% of sector funding
Debt financing
€66M
7.7% of total
Top-10 round share
60.4%
of disclosed capital
Rounds ≥ €100M
1

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, Q4 2023 — interactive chart.
Data table
FundingRounds
Oct€321M44
Nov€286M45
Dec€251M32

Top countries

by € raised
Healthtech — top countries by capital, Q4 2023 — interactive chart.
Data table
Healthtech — top countries by capital, Q4 2023
France€235M
UK€190M
Belgium€105M
Netherlands€78M
Denmark€54M
Germany€44M
Switzerland€41M
Spain€38M

Stage mix

by € raised
Healthtech — stage mix, Q4 2023 — interactive chart.
Data table
Healthtech — stage mix, Q4 2023
Other€354M
Series A€197M
Series C€121M
Debt€66M
Seed€59M
Series B€32M
Grant€19M
Pre-Seed€7.8M
Early VC€1.0M

Exits & M&A

9 Acquisition

9 exits · €1.1B disclosed.

MedAllianceAcquisitionOct 2023€1.1B

Top deals

largest disclosed rounds in Q4 2023
CompanyStageDateAmount
AqemiaOtherDec 2023€129M
Agomab TherapeuticsSeries COct 2023€95M
EyeBiotechSeries ANov 2023€61M
MinervaXOtherOct 2023€54M
In OvoDebtNov 2023€40M
Automata TechnologiesOtherOct 2023€38M
Eligo BioscienceSeries BDec 2023€28M
Memo TherapeuticsSeries CNov 2023€26M
BioserenityOtherNov 2023€24M
ViaNautisSeries ANov 2023€23M
CradleSeries ANov 2023€22M
LUMA VisionSeries ADec 2023€20M
Inbrain NeuroelectronicsDebtDec 2023€20M
LottieSeries AOct 2023€20M
Laverock TherapeuticsSeedOct 2023€16M